Form 4 for TXMD TherapeuticsMD, Inc.
Accepted 2025-02-20 00:00:00 ET · period of report 2025-02-18 · accession 0000905148-25-000740 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-02-20 | 2025-02-18 | TXMD | Collins Cooper C. | Dir | M - OptEx | $0.00 | +8,500 | 60.5K | +16% | $0 |
| D | 2025-02-20 | 2025-02-18 | TXMD | Collins Cooper C. | Dir | M - OptEx | $0.00 | -8,500 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-18 | M | A | 8,500 | $0.00 | 60,516 | D | — | — | |
| 2 | Derivative | Restricted Stock Units | 2025-02-18 | M | D | 8,500 | $0.00 | 0 | D | $0.00 · — to — | 8,500 Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the issuer. On February 18, 2025, the reporting person received 8,500 shares of common stock of the issuer in settlement of RSUs, which vested on July 17, 2024. |